share_log

Virpax Pharmaceuticals Shares Are Trading Higher After Maxim Group Upgraded the Stock From Hold to Buy and Announced a $3 Price Target.

Virpax Pharmaceuticals Shares Are Trading Higher After Maxim Group Upgraded the Stock From Hold to Buy and Announced a $3 Price Target.

维帕克斯药品的股票因Maxim Group将其升级为买入并宣布其股价目标为3美元而上涨。
Benzinga ·  07/19 11:47

Virpax Pharmaceuticals Shares Are Trading Higher After Maxim Group Upgraded the Stock From Hold to Buy and Announced a $3 Price Target.

维帕克斯药品的股票因Maxim Group将其升级为买入并宣布其股价目标为3美元而上涨。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发